Daxor Corporation Announces Year End 2005 Earnings

NEW YORK--(BUSINESS WIRE)--April 18, 2006--Daxor Corporation (AMEX: DXR - News), a medical instrumentation and biotechnology company, today announced the results of operations for the year ended December 31, 2005. The Company had a loss of 29 cents per share in 2005 vs. a restated loss of 8 cents in 2004. The Company had a restatement of its earnings which resulted in an increase in earnings in 2004 and a decrease in 2005. This primarily related to recognition of income from the Company's investments. In addition, the Company's subsidiary division which reported operating revenues on a cash basis, which has now been changed to the accrual basis as required by GAAP. Dividend income and gains on the sales of securities increased 35% in 2005 to $4,026,707 from $2,980,268 in 2004.